Live Breaking News & Updates on Th Ca88338h1001

Stay updated with breaking news from th ca88338h1001. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Theratechnologies Reports Financial Results and Business Updates for First Quarter 2023

Q1 2023 Consolidated Revenue Grew 7%, Supported by 9% Growth in EGRIFTA SV® Revenue and 5% Growth in Trogarzo® Revenue Revised Sudocetaxel Zendusortide Phase 1 Trial. | April 12, 2023 ....

United States , Christian Marsolais , John Leasure , Elif Mcdonald , Philippe Dubuc , Julie Schneiderman , International Accounting Standards Board , Scientific Advisory Committee On , Development Pathway , Communications Corporate Affairs , Scientific Advisory Committee , American Association For Cancer Research , Company Management Discussion , International Financial Reporting Standards , Theratechnologies Inc , Revenue Grew , Sudocetaxel Zendusortide , Guidance Range Confirmed Between , Commercial Portfolio , Term Loan Facility , Marathon Asset , Marathon Asset Management , Loan Facility , Each Marathon Warrant , Opportunistic Infections , Cancer Research ,